The Recall Desk

State

Washington product recalls

73,892 recalls have nationwide distribution and so reach Washington. 8,539 additional recalls listed Washington specifically in their distribution scope.

What the numbers show

Total
8,539
Critical
865
Severe
2,407
Most recent
2026-11-11

Of the 8,539 recalls naming Washington we have scored against our rubric, 865 (10%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 2,407 (28%) are Severe.

These figures cover only the 8,539 recalls whose distribution notice names Washington specifically. The 73,892 nationwide recalls listed below reach every state, so counting them here would make every state page show the same numbers.

63301–63325 of 82431

  • SevereFDA (Drugs)·D-0223-2015·2014-11-12

    FDA Recalls Compounded Testosterone Cypionate Injectable Due to Sterility Concerns

    Oregon Compounding Centers is recalling compounded Testosterone Cypionate injectable vials due to quality control issues affecting sterility assurance.

    Product
    TESTOSTERONE CYPIONATE (GRAPE SEED OIL/COMPOUNDED), 200mg/mL, injectable, 5 mL glass vial, RX, Creative Compounds, Wilsonville, OR 97070
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-0210-2015·2014-11-12

    FDA Recalls Compounded Injectable Drug Due to Sterility Assurance Concerns

    Oregon Compounding Centers is recalling specific lots of a compounded injectable drug due to quality control issues affecting sterility assurance.

    Product
    PAPAVERINE HCL/PHENTOLAMINE/ALPROSTADIL, 21.82mg/0.91mg/45mcg, injectable, 1.7 mL glass vial, RX, Creative Compounds, Wilsonville, OR 97070
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-0192-2015·2014-11-12

    Gentamicin Sulfate Irrigation Solution Recalled for Sterility Assurance Concerns

    Creative Compounds is recalling Gentamicin Sulfate irrigation solution due to quality control issues affecting sterility assurance identified during an FDA inspection.

    Product
    GENTAMICIN SULFATE, 100mg/1000mL, solution for irrigation, 400 mL plastic bottle, RX, Creative Compounds, Wilsonville, OR 97070
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-0220-2015·2014-11-12

    Procaine HCL Injectable Recall Due to Sterility Assurance Concerns

    Oregon Compounding Centers is recalling Procaine HCL injectable vials due to quality control issues affecting sterility assurance.

    Product
    PROCAINE HCL (BUFF), 1%, injectable, 10 mL glass vial, RX, Creative Compounds, Wilsonville, OR 97070
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-0215-2015·2014-11-12

    FDA Recalls Papaverine, Phentolamine, and Alprostadil Injectable Due to Sterility Concerns

    Oregon Compounding Centers is recalling specific lots of a sterile injectable drug due to quality control issues that may compromise sterility.

    Product
    PAPAVERINE/PHENTOLAMINE/ALPROSTADIL, 26.5mg/0.98mg/58.9mcg, injectable, 1.25 mL glass vial, RX, Creative Compounds, Wilsonville, OR 97070
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-0175-2015·2014-11-12

    Recall of Injectable Ascorbic Acid Due to Sterility Assurance Concerns

    Oregon Compounding Centers is recalling injectable Ascorbic Acid (Vitamin B) due to quality control issues affecting sterility assurance identified during an FDA inspection.

    Product
    ASCORBIC ACID (B), 500 mg/mL, injectable, 100 mL glass vial, RX, Creative Compounds, Wilsonville, OR 97070.
    Category
    Drug
    Distribution
    2 states
  • SevereNHTSA·14V727000·2014-11-12

    Hino Recalls 2012-2015 XFC Vehicles Due to Hybrid Motor Shaft Defect

    Hino is recalling 2012-2015 XFC vehicles because the hybrid motor output shaft may break, potentially causing the vehicle to stop moving and increasing crash risk.

    Product
    HINO — HINO XFC
    Category
    Vehicle
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0183-2015·2014-11-12

    Renacidin Solution Recalled for Sterility Assurance Concerns

    Oregon Compounding Centers is recalling Renacidin solution due to quality control issues affecting sterility assurance identified during an FDA inspection.

    Product
    CITRIC ACID/GLUCONOLACTONE MAGNES CARB (RENACIDIN), 66/1.98/31.77 mg/mL, solution for irrigation, 30 mL plastic syringe, RX, Creative Compounds, Wilsonville, OR 97070
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-0218-2015·2014-11-12

    FDA Recalls Papaverine Injectable Due to Sterility Assurance Concerns

    Oregon Compounding Centers is recalling Papaverine/Phentolamine/Prostaglandin injectable vials due to quality control issues affecting sterility assurance.

    Product
    PAPAVERINE/PHENTOLAMINE/PROSTAGLANDIN, 17.64mg/0.58mg/5.8mcg, injectable, 1.7 mL glass vial, RX, Creative Compounds, Wilsonville, OR 97070
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-0187-2015·2014-11-12

    FDA Recalls DMPS Injectable Due to Sterility Assurance Concerns

    Oregon Compounding Centers is recalling DMPS injectable vials due to quality control issues affecting sterility assurance identified during an FDA inspection.

    Product
    DMPS-preservative free, 50 mg/mL, injectable, 5 mL glass vial, RX, Creative Compounds, Wilsonville, OR 97070
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-0199-2015·2014-11-12

    FDA Recalls Hydroxocobalamin Injectable Due to Sterility Assurance Concerns

    Oregon Compounding Centers is recalling Hydroxocobalamin injectable vials due to quality control issues affecting sterility assurance identified during an FDA inspection.

    Product
    HYDROXOCOBALAMIN- preservative (B12), 1mg/mL, injectable, 10 mL glass vial, RX, Creative Compounds, Wilsonville, OR 97070
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-0194-2015·2014-11-12

    FDA Recalls Sterile Glutaraldehyde Solution Due to Quality Control Concerns

    Oregon Compounding Centers is recalling sterile glutaraldehyde solution for irrigation due to quality control issues affecting sterility assurance.

    Product
    GLUTARALDEHYDE BUFFERED (POTASSIUM PHOSPHATE), solution for irrigation, 250 mL glass bottle, RX, Creative Compounds, Wilsonville, OR 97070
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-0177-2015·2014-11-12

    FDA Recalls AVASTIN Syringes Due to Sterility Assurance Concerns

    Oregon Compounding Centers is recalling AVASTIN syringes because quality control issues observed during an FDA inspection present a potential risk to sterility assurance.

    Product
    AVASTIN, 1.25mg/0.5mL, injectable, 0.05 mL plastic syringe, RX, Creative Compounds, Wilsonville, OR 97070.
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-0202-2015·2014-11-12

    Recall of Injectable Methylcobalamin Due to Sterility Assurance Concerns

    Oregon Compounding Centers is recalling injectable Methylcobalamin due to quality control issues affecting sterility assurance.

    Product
    METHYCOBALAMIN, preservative free, 10mg/mL, injectable, 1 mL glass vial, RX, Creative Compounds, Wilsonville, OR 97070
    Category
    Drug
    Distribution
    2 states
  • SevereNHTSA·14V726000·2014-11-12

    Wabash National Van Trailers Recalled for Brake Actuator Defect

    Wabash National is recalling 2014-2016 Van Trailers because defective brake actuators may cause dragging or overheating, increasing the risk of fire and crash.

    Product
    WABASH NATIONAL — WABASH NATIONAL VAN
    Category
    Vehicle
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0208-2015·2014-11-12

    FDA Recalls Compounded Omnipaque Injectable Due to Sterility Concerns

    Oregon Compounding Centers is recalling compounded Omnipaque injectable vials due to quality control issues affecting sterility assurance.

    Product
    OMNIPAQUE, 300mgI/mL, injectable, 2 mL glass vial, RX, Creative Compounds, Wilsonville, OR 97070
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-0174-2015·2014-11-12

    FDA Recalls Alprostadil/Lidocaine Vials Due to Sterility Assurance Concerns

    Oregon Compounding Centers is recalling Alprostadil/Lidocaine HCL vials due to quality control issues affecting sterility assurance identified during an FDA inspection.

    Product
    ALPROSTADIL/LIDOCAINE HCL, 20mcg/5mg/mL, 1.25 mL glass vial, RX, Creative Compounds, Wilsonville, OR 97070.
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-0189-2015·2014-11-12

    FDA Recalls Estradiol Cypionate Injectable Due to Sterility Assurance Concerns

    Oregon Compounding Centers is recalling Estradiol Cypionate injectable vials due to quality control issues affecting sterility assurance identified during an FDA inspection.

    Product
    ESTRADIOL CYPIONATE (COMPOUNDED/GRAPESEED OIL), 5 mg/mL, injectable, 1 ml glass vial, RX, Creative Compounds, Wilsonville, OR 97070
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-0200-2015·2014-11-12

    Hydroxyprogesterone Caproate Injectable Recalled for Sterility Assurance Concerns

    Oregon Compounding Centers is recalling Hydroxyprogesterone Caproate injectable vials due to quality control issues affecting sterility assurance identified during an FDA inspection.

    Product
    HYDROXYPROGESTERONE CAPROATE (SESAME OIL), 250mg/mL, injectable, 5 mL glass vial, RX, Creative Compounds, Wilsonville, OR 97070
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-0212-2015·2014-11-12

    FDA Recalls Sterile Injectable Drug Due to Quality Control Concerns

    Oregon Compounding Centers is recalling sterile injectable drug vials due to quality control issues affecting sterility assurance.

    Product
    PAPAVERINE HCL/PHENTOLAMINE MES/ALPROSTADIL, 22mg/0.8mg/8mcg, injectable, 1.25 mL glass vial, RX, Creative Compounds, Wilsonville, OR 97070
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-0225-2015·2014-11-12

    Tobramycin Solution Recalled for Sterility Assurance Concerns

    Oregon Compounding Centers is recalling Tobramycin solution for irrigation due to quality control issues affecting sterility assurance.

    Product
    TOBRAMYCIN, 480mg/1000 mL, solution for irrigation, 500 mL plastic bottle, RX, Creative Compounds, Wilsonville, OR 97070
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-0182-2015·2014-11-12

    FDA Recalls Chorionic Gonadotropin Vials Due to Sterility Assurance Concerns

    Oregon Compounding Centers is recalling 117 vials of Chorionic Gonadotropin due to quality control issues affecting sterility assurance.

    Product
    CHORIONIC GONADOTROPIN, 5000 Units, sterile powder for reconstitution, glass vial, RX, Creative Compounds, Wilsonville, OR 97070
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Devices)·Z-0084-2015·2014-11-12

    Baxter INTRA VIA Container Recalled for Particulate Matter in Fluid Path

    Baxter Healthcare Corp is recalling 94,224 INTRA VIA containers due to particulate matter found inside the fluid path.

    Product
    Baxter 2B8011 Empty INTRA VIA Container with PVC Ports, Sterile fluid path, 150 ml, Admixture Products and Accessories. The lntraVia Empty Plastic Container is intended for use in the preparation and administration of drug admixtures.
    Category
    Medical Device
    Distribution
    Distributed nationwide